Back to search

University of Hull

Development of porphyrin-antiangiogenic antibody immunoconjugates for photodynamic therapy

Abstract

dc:description.abstract

Photodynamic therapy is a novel cancer treatment, involving the combination of light, photosensitiser and molecular oxygen to produce cytotoxic species. Currently, commercially available photosensitisers, including Photofrin and Foscan, only exhibit a passive selectively towards cancerous tissue. Therapeutically, this results in a variety of unfavourable characteristics, obstructing PDT from becoming a more viable cancer treatment. Research has been directed towards improving the pharmacokinetic and biodistribution profiles of photosensitisers, which can be achieved by conjugating the photosensitiser moiety to a biomolecule which has affinity for the diseased tissue; these 3rd generation photosensitisers include photoimmunoconjugates.Three synthetic routes were developed, with the aim of producing novel bioconjugatable porphyrins, which could be subsequently conjugated to cysteine residues expressed by a suitable monoclonal antibody (SIP(L19)). Two cationic, thiol reactive photosensitisers were synthesised and successfully conjugated to SIP(L19) in a reproducible manner, affording well defined immunoconjugates, which retained both the immunoreactivity of the antibody moiety and the photoactivity of the photosensitiser. The effect of the length and hydrophilicity of the linker connecting the photosensitiser and bioconjugatable group was investigated, and it was observed that the photoactivity of the immunoconjugate was enhanced using a longer, hydrophilic chain. Synthetic routes leading to the production of bioconjugatable porphyrin dimers, and photosensitisers from symmetrical porphyrin, were developed, but failed to yield final products.

Degree

thesis:*
Name dc:type.qualificationname
PhD
Level dc:type.qualificationlevel
Doctoral
Grantor dc:publisher.institution
University of Hull
Year dc:date.issued
2010

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bullous, Aaron
Advisor dc:contributor.advisor
  • Boyle, Ross

Subjects

dc:subject × 1

Rights

Language dc:language
en

Identifiers

dc:identifier.*
Identifier
oai:hull-repository.worktribe.com:4211381
OAI identifier oai:identifier
oai:hull-repository.worktribe.com:4211381

Chain of custody

source
Harvested from
University of Hull
Base URL
hull-repository.worktribe.com/oaiprovider
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Bullous, Aaron. Development of porphyrin-antiangiogenic antibody immunoconjugates for photodynamic therapy. Doctoral thesis, University of Hull, 2010. https://hull-repository.worktribe.com/4211381/1/Thesis